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CRISPR/Cas9 technology is a highly promising genome editing tool in the mouse, potentially over-
coming the costs and time required for more traditional gene targeting methods in embryonic stem
(ES) cells. Recently, compared to the wildtype nuclease, paired Cas9 nickase (Cas9n) combined with
single guide RNA (sgRNA) molecules has been found to enhance the speciﬁcity of genome editing
while reducing off-target effects. Paired Cas9n has been shown to be as efﬁcient as Cas9 for gener-
ating insertion and deletion (indel) mutations by non-homologous end joining and targeted dele-
tion in the genome. However, an efﬁcient and reliable approach to the insertion of loxP sites
ﬂanking critical exon(s) to create a conditional allele of a target gene remains an elusive goal. In this
study, we microinjected Cas9n RNA with sgRNAs together with a single DNA template encoding two
loxP sites ﬂanking (ﬂoxing) exon 2 of the isoprenoid synthase containing domain (Ispd) into the pro-
nucleus and cytoplasm of C57BL/6NCr one-cell stage zygotes. After surgical transfer, one F0 mouse
expressing a conditional allele was produced (at a frequency of 8% of live pups born). The ﬂoxed
allele was transmitted through the germline to F1 progeny, and could be successfully recombined
using Cre recombinase. This study indicates that conditional targeting can be accomplished
effectively using paired Cas9n and a single DNA template.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Gene knockout mice have traditionally been derived by gene
targeting in mouse embryonic stem (ES) cells [1,2]. Although
highly effective, multiple interdependent methods and procedures
are required, including design and construction of a molecular tar-
geting vector, electroporation, culture, and selection of ES cells,
screening identiﬁcation, and expansion of homologously recom-
bined ES cell clones, blastocyst microinjection of gene targeted
ES cells, and production and breeding of chimeras to conﬁrm germ-
line transmission. All these steps are commonly used for routine
generation of genome-modiﬁed ‘‘knockout’’ mice. This process is
also time-consuming (7–8 months or longer) and expensive, with
no guarantee of success.Gene targeting in ES cells relies on homologous recombination,
during which DNA sequence homologous to the target sequence
encoded by an engineered molecular vector construct is used to
align and hybridize with the endogenous sequence of the target
gene. Sequence exchange of geneticmaterial is facilitated by double
stand breaks (DSBs) and rejoining of the two broken ends, thereby
incorporating the targeting construct [3,4]. Unfortunately, homolo-
gous recombination occurs at a relatively low frequency and thus
requires the use of drug selection when targeting in ES cells. In
addition, successful germline transmission from chimeras gener-
ated after blastocyst injection of ES cells is one of the major hurdles
to successfully producing knockout mice using this technology.
A new approach to try to overcome these hurdles uses DNA
nucleases, such as zinc ﬁnger nucleases (ZFNs) and transcription
activator-like effector nucleases (TALENs).In a site-speciﬁc manner,
these nucleases generate DSBs which can be repaired by homology
directed repair (HDR) in the presence of a single-stranded oligonu-
cleotide or double-stranded DNA template. This approach allows
for genome modiﬁcation through site-speciﬁc DNA nuclease action
followed by HDR. More recently, DNA nuclease technology using
Clustered Regularly Interspaced Short Palindromic Repeat
(CRISPR)/CRISPR associated protein (Cas) has been shown to have
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ing in mice. CRISPR/Cas is a self-defense system found in bacteria
against foreign genetic material [5,6]. Cas9 is a type II Cas protein
that, in association with single strand guide RNA (sgRNA), can rec-
ognize and generate DSBs at a target DNA sequence [7]. In fact,
Cas9 has been shown to bean effective genome editing tool in
mammalian cells [8–10] and embryos of a variety of species,
including drosophila [11,12], zebra ﬁsh [13,14], mouse and rat
embryos [15–17], and non-human primates [18].
Compared with traditional gene targeting in ES cells, Cas9 is
potentially faster, easier to design, and a less expensive method
for genome modiﬁcation. A potential drawback as a result of off-
target genetic mutations induced by promiscuous cutting by
Cas9 nuclease can be spurious and unintended phenotypic conse-
quences [19,20]. To address this issue, a mutation altering one
amino acid at position D10A introduced into wildtype Cas9
replaced its double-strand nuclease activity with single-strand cut-
ting (‘‘nickase’’) activity at the DNA target site [21,22]. Another
impact of this change in enzymatic activity is that Cas9 nickase
(Cas9n) co-associated with two complementary, or paired sgRNAs
is reported to have a lower frequency of off-target effects com-
pared to wildtype Cas9 [23–26].
Cas9 and Cas9n have been used to generate insertions, dele-
tions, and exon replacements in genetically modiﬁed mice after
injection into one-cell stage zygotes [27,28]. However, there are
few reports using site-speciﬁc Cas9n to generate more complex
alleles, such as conditional-ready (ﬂoxed) alleles, in the mouse
genome. Floxed alleles, which retain wildtype (normal) expression
until after being acted upon by a site-speciﬁc recombinase in a
time- or tissue/cell type-speciﬁc manner [29] have signiﬁcant
advantages over general gene knockout approaches, such as when
a whole body gene knockout causes embryonic lethality [30]. The
ﬂexibility and versatility of conditional alleles for studying gene
function is reﬂected in the NIH’s KnockOut Mouse Project
(KOMP),in which most of the genes are conditionally targeted in
ES cells using the Cre/lox system [31].ATG
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Fig. 1. Generation of an Ispd conditional allele by Cas9n. (A) Schematic diagram of ﬁrst 2
for homologous recombination by Cas9n/sgRNA; sgRNA target sites in exon2 are underli
font; single DNA template consisting of two loxP sites (yellow triangle) surroundingexon
and R1 (orange triangles) used for genotype screening of F0 offspring; a conditional, ﬂo
template at the target locus. (B) 1% Agarose gel showing amplicons (wildtype band 59
wildtype pups (shown in lanes 1–6 and 8–13) from those in which the single DNA templa
amplicons, one of which (629 bp) is the expected size for a targeted insertion of one loxP
ladder). (For interpretation of the references to color in this ﬁgure legend, the reader isEfforts to date include two separate Cas9 targeting events
guided by their associated sgRNAs and two loxP-containing DNA
oligos to insert loxP sites in F0 mice after zygote injection
[28].However, it has not been reported whether a functional condi-
tional allele generated in this fashion transmits through the germ-
line. The efﬁciency of this approach is the sum of the efﬁciencies of
each of 2 separate Cas9and homologous recombination events. In
contrast, a different approach using a paired Cas9n and a single
DNA template incorporating loxP sites ﬂanking a critical exon
should be more efﬁcient. Further, using paired Cas9n instead of 2
separate Cas9sshould reduce the incidence of off-target effects
and further enhance the process, especially in a high-throughput
production pipeline. If successful, this approach could be of
signiﬁcant beneﬁt to advancing genetic studies and biomedical
research.
To test this hypothesis, in the present experiments we
co-injected paired Cas9n with sgRNAs and a single DNA template
into C57BL/6NCrl zygotes to generate F0 mouse expressing a con-
ditional allele of the isoprenoid synthase domain containing (Ispd)
gene. We observed a genotypically-conﬁrmed ﬂoxed allele and
sequence-veriﬁed targeting efﬁciency in 1 F0 mouse (8% of live
pups born). We conﬁrmed germline transmission and functional
recombination of the ﬂoxed allele. This approach demonstrates
the relative ease and reliability of generating conditional alleles
using Cas9nand a single DNA template.
2. Results
2.1. Gene targeting strategy
The Ispd gene contains 10 exons spanning 307.9 kb on chromo-
some 12. To maximize cleavage at the target site [26], complemen-
tary sgRNAs (sgRNA 1 and sgRNA 2) separated by a 20 bp spacer
were designed (Fig. 1A). The targeting vector encoded a single
DNA template consisting of 1.9 kb arms of homologous genomic
sequence immediately upstream (50) and downstream (30) of exon2
GAGGACTCTCAACAGAATCGTCGATTC 5’
2
5’ TGAGTGTTTGACACTATAATGGGTAAGGGACAA 3’
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exons of the wildtype Ispd allele with relative position of single DNA template used
ned (sgRNA 1 and 2) with protospacer-adjacent motif (PAM) sequence shown in red
2 of Ispd (608 bp) ﬂanked by arms of genomic homology(1.9 kb); PCR primers L1
xed exon 2 allele is generated after homologous recombination of the single DNA
5 bp; mutant bands 629 and >629 bp) generated by PCR screening to discriminate
te had inserted into the genome (shown in lane 7); DNA from pup 7 shows two PCR
site, and the other (675 bp) indicates the presence of an indel mutation (1 kb DNA
referred to the web version of this article.)
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strategy was chosen because following Cre recombination, excision
of exon 2 will lead to a frameshift mutation followed by nonsense-
mediated mRNA decay, resulting in premature translation of ISPD
protein, and a knockout of the Ispd gene.
2.2. Generation of genome-modiﬁed mice with conditional allele
The pronuclei and cytoplasm of 108 C57Bl/6N zygotes were
injected with paired Cas9nwith associated sgRNAs, and the single
DNA template under continuous pneumatic pressure. Following
injection, zygotes were developed to 2-cell stage embryos over-
night in a 5.5% CO2 incubator before surgical transfer into the ovi-
ducts of female CD1 pseudopregnant recipient mice. Thirteen F0
pups (18% birthrate) were born (Table 1). We designed a simple
short range PCR to quickly screen offspring to discriminate wild-
type pups from those in which the single DNA template had
inserted into the genome (Fig. 1A, primers L1 & R1). Of these, 1
pup (founder 7) exhibited bi-allelic mutation of the intended target
site (Fig. 1B), as indicated by the absence of a wildtype PCR ampli-
con (595 bp) and the presence of a mutant PCR amplicon (629 bp)
corresponding to the expected size of the homologous region in the
single DNA template and one loxP site. A second larger mutant PCR
amplicon (>629 bp) was also identiﬁed represented an indel
mutation.Table 1
Microinjection data for Cas9n generation of a conditional allele of Ispd by homologous rec
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Fig. 2. Long range PCR strategy to conﬁrm homologous recombination of the single DN
triangles) and L3 & R2 (purple triangles) used to PCR amplify genomic DNA from pup
homology region of the single DNA template used as the targeting vector (other details
(2.8 kb, L2 & R1; 2.2 kb, L3 & R2) were cloned for DNA sequencing. (C) DNA sequence
intact loxP sites ﬂanking (upstream and downstream) exon2. (For interpretation of the ref
article.)2.3. Conﬁrmation of Ispd ﬂoxed allele
The genomic positioning of primers for rapid PCR screening of
offspring could not be used to distinguish between random inser-
tions and homologous recombination of the single DNA template
at the targeted locus. Therefore, to deﬁnitively conﬁrm conditional
targeting of the Ispd allele and to discern between the 2 mutant
amplicons identiﬁed in founder pup 7, we designed longer PCR
ampliﬁed regions using primer pairs homologous to genomic
sequence external to the targeting construct (Fig. 2). In one PCR
reaction, primer L2 located upstream of the 50 homology arm
sequence and primer R1 positioned at the 30 end of exon 2
(Fig. 2A) produced a PCR product (2.8 kb) which was subcloned
by T/A cloning for DNA sequencing (Fig. 2B). Out of 18 clones, 12
were correctly targeted with loxP ﬂanked exon 2 of one allele
(Fig. 2C). The other 6 clones identiﬁed an allele containing only
one loxP site (downstream of exon2) and a 95 bp insertion at the
nick site targeted by sgRNA1 (Supplementary Fig. S1). In a second
PCR reaction, primer L3 located downstream of exon 2 and primer
R2 located downstream of the 30 homology arm sequence (Fig. 2A)
produced a PCR product (2.2 kb) that was subcloned by T/A clon-
ing for DNA sequencing (Fig. 2B). As predicted, all seven clones
showed a single loxP site downstream of exon 2. The combined
DNA sequencing data of 2.8 kb and 2.2 kb amplicons from the
2 PCR reactions described above conﬁrmed thatexon2 in one alleleombination in mice.
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Fig. 3. Germline transmission and in vitro Cre recombination of the Ispd conditional allele. (A) 1% Agarose gel showing PCR ampliﬁcation of genomic DNA from F0 pup 7
(629 bp and 675 bp), F1 pup 1 (595 bp and 629 bp) and a wildtype pup (595 bp) using PCR primers L1 & R1 (same as in Fig. 1A). (B) After treatment with Cre
recombinase in vitro, genomic DNA from F1 pup 1 used as template for PCR ampliﬁcation with primers L4 and R1 ﬂanking the ﬂoxed exon 2 produced a deletion product with
two amplicons, a Cre-recombined band (351 bp) and a wildtype band (925 bp); PCR primers R3 and L5 ampliﬁed the circular DNA product (502 bp) containing the
expected single loxp site and exon 2 resulting after Cre recombinationtreatment.
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complementary allele incorporated only one loxP site.
2.4. Conﬁrmation of germline transmission and functionality of the
ﬂoxed allele
The ﬁrst litter (F1) from breeding founder pup 7 (female) and
C57BL/6N (male) produced one pup. Allele-speciﬁc PCR of DNA
extracted from tail tissue conﬁrmed germline transmission of the
ﬂoxed Ispd allele (Fig. 3A). To conﬁrm functionality of the condi-
tional allele, genomic DNA from the F1 offspring was treated with
recombinant Cre protein in vitro. Compared to wildtype genomic
DNA, allele-speciﬁc PCR conﬁrmed recombination of the ﬂoxed
allele and the presence of the expected circular deletion product
(Fig. 3B). These results further support the use of paired Cas9n
and a single DNA template to achieve germline transmission of a
functional ﬂoxed allele.
3. Discussion
To our knowledge, this is the ﬁrst study to demonstrate the suc-
cessful generation of a conditional knockout (ﬂoxed) allele in mice
using paired Cas9n with a single DNA template expressing a loxP-
ﬂanked critical exon for targeting by homologous recombination.
DNA cleavage induced by paired Cas9n enabled the single DNA
template to undergo homologous recombination at the target site.
Because this was a relatively small study, only 1 pup (8% of live
born offspring) expressed the mutant allele. Further, although
low, the overall efﬁciency (1% of injected zygotes) was within
the range for other HDR and homologous recombination targeting
experiments using Cas9 [28]. Using paired Cas9n and a single DNA
template is simpler and easier than previously described methods
using two separate cutting events using Cas9 and two donor oligo-
nucleotides [28]. Further, an earlier study used Cas9 and a single
DNA template to generate conditional alleles in rats. [32]. In
addition, compared to Cas9, fewer off-target effects makes the
use of Cas9n and a single DNA template as in our experiment a
compelling approach to the production of conditional alleles in
mice. In many previous publications, Cas9 and Cas9n have beenused to generate mutant mice on genetically hybrid and mixed
backgrounds [25,27,28]. Our study focused on Cas9n targeting in
an inbred (C57Bl/6NCrl) strain that is particularly desirable strain
for high-throughput phenotyping studies of mouse models for
human disease. Our experiments in C57BL/6N show that paired
Cas9n can be used to generate conditional alleles in inbred strains.
Further, our study conﬁrms not only functionality of the ﬂoxed
allele but also germline transmission of the targeted allele.
We chose to conduct this pilot study using the Ispd gene
because a conditional allele for this gene has not yet been
described in the literature, nor has it been targeted by the large
International Mouse Phenotyping Consortium (IMPC) production
and phenotyping projects currently underway (http://www.mous-
ephenotype.org/). Mutations in the ISPD gene in humans have been
associated with Walker–Warburg Syndrome, a neurodevelopmen-
tal disorder [33,34]. A mutant Ispd mouse containing a premature
stop codon in exon 1 leading to a truncated protein was generated
by chemical-induced random mutagenesis using N-Ethyl-N-
Nitrosourea (ENU) [35]. Homozygous mutants died at birth due
to respiratory failure, and E18 embryos exhibited defects in the
formation of the dorsal funiculus [33]. Conditional mutagenesis is
particularly useful to study genes in which homozygous deletion
mutation results in embryonic lethality. Our study exempliﬁes
the application of a simpler and easier approach using paired
Cas9n for creating a germline competent and functional
conditional allele for potentially embryonic lethal genes in mice.
4. Materials and methods
4.1. Preparation of sgRNA transcripts and targeting vector
DNA oligos were obtained from Life Technologies (Grand Island,
NY). Oligos were heated to 95 C and then cooled to room temper-
ature. The self-annealing oligo duplex was cloned into linearized
T7 gRNA vector (System Biosciences, Mountain view, CA USA),
and sequence veriﬁed by DNA sequencing. The sgRNA template
for in vitro transcription (IVT) was prepared by PCR ampliﬁcation
of Phusion high ﬁdelity DNA polymerase (NEB Biolabs, Ipwich,
MA) followed by PCR cleanup reaction (Qiagen, Hilden, Germany).
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tem Biosciences) and the quality of sgRNA transcripts were ana-
lyzed by NanoDrop (Thermo Fisher Scientiﬁc (Waltham, MA) and
Bioanalyzer instrument (Agilent Technologies, Inc., Santa Clara,
CA). The gene targeting vector encoding a single DNA template
containing a ﬂoxed Ispd exon 2 was generated by GeneArt Gene
Synthesis (GeneArt, Regensburg) and sequence veriﬁed. The single
DNA template was released from the gene targeting vector by
restriction enzyme XhoI (NEB Biolabs) and was gel puriﬁed from
agarose gel (Lonza, Rockland, ME) before microinjection.
4.2. Microinjection
C57BL/6NCr female mice (3–4 weeks olds) were super ovulated
and mated overnight with C57Bl/6NCr male mice (>7 weeks old).
Zygotes were harvested from the ampullae of super ovulated
females and were placed in KSOM medium (Millipore, Billerica,
MA) before microinjection. Microinjection was performed in M2
medium (Sigma, St Louis, MO) using a micromanipulator (Narishi-
ge) and microscope (Nikon). The Cas9n (System Biosciences),
sgRNA and a single DNA template were co-injected into the pronu-
cleus and cytoplasm of 108 zygotes. The ﬁnal injection concentra-
tion in the mixture was 10 ng/ll Cas9n, 5 ng/ll of each sgRNA and
10 ng/ll of the single DNA template. After injection and incubation
in 5.5% CO2 at 37 C overnight for 24 h, surviving 2-cell stage
embryos were transferred to CD1 recipients via oviduct transfer.
4.3. Use of animals
All mice were housed in a speciﬁc pathogen free vivarium with
a 14 h on/10 h off light cycle (7 am on and 9 pm off). Female pseu-
dopregnant mice undergoing surgical transfer of embryos into the
uterus were anesthetized using Avertin (1.2%, 2,2,2, tribromoetha-
nol, Sigma, St Louis, MO)at a dose of 0.017 ml/g of body weight
administrated intraperitoneally. For post-operative pain relief,
0.1 ml of 0.03 mg/ml buprenorphine hydrochloride (Buprenex,
Reckitt Becnkiser Healthcare, Hull, England) was administered
intraperitoneally. Euthanasia was performed by CO2 asphyxiation
and cervical dislocation according to the 2013 AVMA Guidelines
on Euthanasia. The care, use, and disposition of all mice used in this
study were reviewed and approved by the Institutional Animal
Care and Use Committee of the University of California, Davis.
4.4. Genotyping of founders
At 10 days of age, toe snips of surviving F0 mice were harvested
and genomic DNAwas extracted using the DNeasy blood and tissue
kit (Qiagen). The target region was PCR ampliﬁed by DNA polymer-
ase (Agilent Technologies, Inc) followed by DNA sequencing for
screening F0 offspring. In pups showing positive PCR reactions for
the single DNA template, genomic DNA was further PCR ampliﬁed
to produce amplicons that were subsequently cloned by TOPO T/A
subcloning (Invitrogen, Carlsbad, CA) followed by DNA sequencing.
4.5. In vitro Cre recombination
1 lg genomic DNA was mixed with 10 units of recombinant Cre
recombinase (NEB Biolabs) in 1X Cre recombinase reaction buffer
(supplementary with Cre recombinase) with ﬁnal volume of
40 ll. The mixture was incubated in 37 C for 1 h and then the
reaction was heat inactivated at 70 C for 10 min. For all targets,
2 ll of Cre reaction mix was used as a PCR template for PCR ampli-
ﬁcation with gene-speciﬁc primers. Primers (L4 and R1) were used
for detection of deletion products, while primers (R3 and L5) were
used for detection of the circular DNA byproduct remaining after
Cre-mediated recombination.Acknowledgments
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